DATA FORM FOR CANCER STAGING - CARCINOMA OF THE EYELID
Form # 785-1-050
| CLIN | PATH | DEFINITIONS | |
| PRIMARY TUMOR (T) | |||
| TX | Primary tumor cannot be assessed | ||
| T0 | No evidence of primary tumor | ||
| Tis | Carcinoma in situ | ||
| T1 | Tumor of any size, not invading the tarsal plate or, at the eyelid margin, 5 mm or less in greatest dimension | ||
| T2 | Tumor invades tarsal plate or, at the eyelid margin, more than 5 mm but not more than 10 mm in greatest dimension | ||
| T3 | Tumor involves full eyelid thickness or, at the eyelid margin, more than 10 mm in greatest dimension | ||
| T4 | Tumor invades adjacent structures | ||
| LYMPH NODE (N) | |||
| NX | Regional lymph nodes cannot be assessed | ||
| N0 | No regional lymph node metastasis | ||
| N1 | Regional lymph node metastasis | ||
| DISTANT METASTASIS (M) | |||
| MX | Presence of distant metastasis cannot be assessed | ||
| M0 | No distant metastasis | ||
| M1 | Distant metastasis | ||
| STAGE GROUPING No stage grouping is presently recommended |
THE FINAL STAGE GROUPING (CLINICAL & PATHOLOGICAL) IS THE RESPONSIBILITY OF THE ATTENDING PHYSICIAN.
| Comments: |
| Patient Name: |